BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24635793)

  • 1. Donor-transmitted, donor-derived, and de novo cancer after liver transplant.
    Chapman JR; Lynch SV
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():50-4. PubMed ID: 24635793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor transmitted and de novo cancer after liver transplantation.
    Desai R; Neuberger J
    World J Gastroenterol; 2014 May; 20(20):6170-9. PubMed ID: 24876738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic disease after liver transplantation: Focus on de novo neoplasms.
    Burra P; Rodriguez-Castro KI
    World J Gastroenterol; 2015 Aug; 21(29):8753-68. PubMed ID: 26269665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of de novo cancer in liver transplant recipients.
    Riis TH; Møller DL; Høgh J; Knudsen AD; Rostved AA; Akdag D; Kirkby N; Lassen U; Rasmussen A; Hillingsø JG; Pommergaard HC
    APMIS; 2023 Apr; 131(4):135-141. PubMed ID: 36680559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Pandanaboyana S; Longbotham D; Hostert L; Attia M; Baker R; Menon K; Ahmad N
    Transpl Int; 2016 Jan; 29(1):73-80. PubMed ID: 26402442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of de novo malignancy in the liver transplant recipient.
    Chandok N; Watt KD
    Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
    Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
    PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
    Bhat M; Mara K; Dierkhising R; Watt KDS
    Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-derived metastatic melanoma in a liver transplant recipient established by DNA fingerprinting.
    Bilal M; Eason JD; Das K; Sylvestre PB; Dean AG; Vanatta JM
    Exp Clin Transplant; 2013 Oct; 11(5):458-63. PubMed ID: 23534438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
    Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
    Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant malignancies in liver transplant recipients.
    Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deceased-Donor Smoking History Is Associated With Increased Recipient Mortality After Kidney Transplant: A Population-Cohort Study.
    Gillott H; Jackson Spence F; Tahir S; Hodson J; Nath J; Sharif A
    Exp Clin Transplant; 2019 Apr; 17(2):183-189. PubMed ID: 29766775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumours after kidney transplantation.
    Lutz J; Heemann U
    Curr Opin Urol; 2003 Mar; 13(2):105-9. PubMed ID: 12584469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report.
    Tamè M; Calvanese C; Cucchetti A; Gruppioni E; Colecchia A; Bazzoli F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):387-9. PubMed ID: 26405713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer transmission from organ donors-unavoidable but low risk.
    Desai R; Collett D; Watson CJ; Johnson P; Evans T; Neuberger J
    Transplantation; 2012 Dec; 94(12):1200-7. PubMed ID: 23269448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.
    Berardinelli L; Raiteri M; Beretta C; Pasciucco A; Giussani A; Carini M; Marenghi C; Rossetti A; Piccolo G
    Clin Transpl; 2011; ():99-110. PubMed ID: 22755406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High clinical suspicion of donor-derived disease leads to timely recognition and early intervention to treat solid organ transplant-transmitted lymphocytic choriomeningitis virus.
    Mathur G; Yadav K; Ford B; Schafer IJ; Basavaraju SV; Knust B; Shieh WJ; Hill S; Locke GD; Quinlisk P; Brown S; Gibbons A; Cannon D; Kuehnert M; Nichol ST; Rollin PE; Ströher U; Miller R
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28423464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on liver transplantation: A critical review.
    Neuberger J
    J Autoimmun; 2016 Jan; 66():51-9. PubMed ID: 26350881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.